T. Skeie-Jensen

Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas

D. Bell, B. Davidson, J. Carlson, 2017, The American journal of surgical pathology.

Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II)

E. Verdaasdonk, H. Grabsch, J. Monson, 2021, BJS open.

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)

V. Gebski, S. Grénman, G. Kristensen, 2017, British Journal of Cancer.

Pegylated liposomal doxorubicin and carboplatin (C-PLD) versus paclitaxel and carboplatin (C-P) in platinum-sensitive ovarian cancer (OC) patients (pts): Treatment at recurrence and overall survival (OS) final analysis from CALYPSO phase III GCIG trial.

V. Gebski, I. Vergote, S. Pignata, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Minimum standards of pelvic exenterative practice: PelvEx Collaborative guideline.

Dwight A. Larson, P. Sutton, Ionut Negoi, 2022, The British journal of surgery.

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer.

V. Gebski, R. Simes, J. Ledermann, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma

H. Danielsen, B. Davidson, B. Katz, 2017, Virchows Archiv.

Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma.

I. Shih, V. Abeler, Li Chen, 2013, Gynecologic oncology.

Reliability of core needle biopsy for determining ER and HER 2 status in breast cancer

V. Gebski, R. Simes, G. Kristensen, 2013 .

Pelvic exenteration for vulvar cancer: Postoperative morbidity and oncologic outcome - A single center retrospective analysis.

G. Kristensen, K. Lindemann, Y. Wang, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)

V. Gebski, S. Grénman, G. Kristensen, 2017, British Journal of Cancer.

Stathmin is an Independent Prognostic Marker of Poor Outcome in Uterine Leiomyosarcoma.

T. Skeie-Jensen, A. Holth, B. Davidson, 2024, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.